About this trial
To date, there has been no head to head comparison of Upper Airway Stimulation (UAS) and Continuous Positive Airway Pressure (CPAP) utilizing a full night polysomnographic evaluation. With this study we aim to evaluate a pilot cohort of patients with OSA treated with CPAP or UAS using the WatchPAT polysomnography system.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Age greater than 22 years old
History of moderate to severe OSA (AHI 15-65)
UAS implantation with postoperative titration and demonstrated successful use of therapy or has demonstrated the ability to tolerate CPAP for greater than 4 hours per night 5 days per week.
Disqualifiers
none
Trial population
Patients using upper airway stimulation or continuous positive airway pressure
Trial design
Cohort
Prospective
Treatments tested in this trial
Not listed
Trial groups
Trial outcomes
Primary outcomes
Difference in polysomnography (PSG) data between UAS and CPAP groups
Difference in Epworth Sleepiness Scale questionnaire data between UAS and CPAP groups
Difference in Functional Outcomes of Sleep questionnaire data between UAS and CPAP groups
Sponsors and contacts
Click on the lead sponsor to view all of their trials.